SPARC’s activation is mediated through the phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K) signaling pathway linked to Insulin-like Growth Factor 1 (IGF-1) [20], making it vital for the prevention of sarcopenia. Here, SPARC is linked to sarcopenia.